UY29124A1 - QUINOLINE COMPOUNDS - Google Patents
QUINOLINE COMPOUNDSInfo
- Publication number
- UY29124A1 UY29124A1 UY29124A UY29124A UY29124A1 UY 29124 A1 UY29124 A1 UY 29124A1 UY 29124 A UY29124 A UY 29124A UY 29124 A UY29124 A UY 29124A UY 29124 A1 UY29124 A1 UY 29124A1
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- levels
- certain
- triglycerides
- quinoline compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Compuestos de quinolina, composiciones farmacéuticas que contienen tales compuestos y el uso de tales compuestos para elevar ciertos niveles de lípidos en plasma, incluyendo el colessterol asociado a lipoproteínas de alta densidad y para reducir otros ciertos niveles de lípidos en plasma, tales como el colesterol LDL y los triglicéridos y, por consiguiente, para tratar enfermedades que están exacerbadas por bajos niveles de colesterol HDL y/o altos niveles de colesterol LDL y triglicéridos, tales como la aterosclerosis y enfermedades cardiovasculares en ciertos mamíferos incluyendo los seres humanos.Quinoline compounds, pharmaceutical compositions containing such compounds and the use of such compounds to raise certain levels of plasma lipids, including colessterol associated with high density lipoproteins and to reduce other certain levels of plasma lipids, such as LDL cholesterol and triglycerides and, therefore, to treat diseases that are exacerbated by low levels of HDL cholesterol and / or high levels of LDL cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in certain mammals including humans.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61286304P | 2004-09-23 | 2004-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY29124A1 true UY29124A1 (en) | 2006-04-28 |
Family
ID=35511128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY29124A UY29124A1 (en) | 2004-09-23 | 2005-09-20 | QUINOLINE COMPOUNDS |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20070149567A1 (en) |
| AR (1) | AR054085A1 (en) |
| GT (1) | GT200500264A (en) |
| NL (1) | NL1030012C2 (en) |
| PE (1) | PE20060819A1 (en) |
| TW (1) | TW200616964A (en) |
| UY (1) | UY29124A1 (en) |
| WO (1) | WO2006033004A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003269327A1 (en) * | 2002-10-21 | 2004-05-04 | Warner-Lambert Company Llc | Tetrahydroquinoline derivatives as crth2 antagonists |
| PT1740591E (en) | 2004-04-02 | 2009-09-24 | Osi Pharm Inc | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| WO2007107843A1 (en) * | 2006-03-22 | 2007-09-27 | Pfizer Products Inc. | Methods of treatment with cetp inhibitors |
| JP2012524119A (en) | 2009-04-20 | 2012-10-11 | オーエスアイ・ファーマシューティカルズ，エルエルシー | Preparation of C-pyrazine-methylamine |
| CA2809958A1 (en) | 2010-08-31 | 2012-03-08 | Snu R & Db Foundation | Use of the fetal reprogramming of a ppar ? agonist |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT199900147A (en) * | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- TETRAHIDROQUINOLINAS 2-SUBSTITUTED 4-AMINO SUBSTITUTED. | |
| CO5271716A1 (en) * | 1999-11-30 | 2003-04-30 | Pfizer Prod Inc | CRYSTALS OF 4- CARBOXAMINE 1,2,3,4-TETRAHYDROQUINOLINE 2- REPLACED |
| MXPA05010456A (en) * | 2003-03-28 | 2006-03-21 | Pfizer Prod Inc | 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity. |
| MXPA06003499A (en) * | 2003-09-30 | 2006-06-08 | Pfizer Prod Inc | Cetp inhibitors and metabolites thereof. |
-
2005
- 2005-09-12 US US10/576,853 patent/US20070149567A1/en not_active Abandoned
- 2005-09-12 WO PCT/IB2005/002890 patent/WO2006033004A1/en active Application Filing
- 2005-09-20 PE PE2005001089A patent/PE20060819A1/en not_active Application Discontinuation
- 2005-09-20 TW TW094132466A patent/TW200616964A/en unknown
- 2005-09-20 UY UY29124A patent/UY29124A1/en not_active Application Discontinuation
- 2005-09-21 AR ARP050103955A patent/AR054085A1/en unknown
- 2005-09-22 GT GT200500264A patent/GT200500264A/en unknown
- 2005-09-22 NL NL1030012A patent/NL1030012C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AR054085A1 (en) | 2007-06-06 |
| PE20060819A1 (en) | 2006-09-02 |
| NL1030012C2 (en) | 2006-11-21 |
| US20070149567A1 (en) | 2007-06-28 |
| GT200500264A (en) | 2006-06-02 |
| TW200616964A (en) | 2006-06-01 |
| NL1030012A1 (en) | 2006-03-27 |
| WO2006033004A1 (en) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29222A1 (en) | COMPOUNDS AND DERIVATIVES OF DIBENCIL AMINA | |
| CR10265A (en) | COMPOUNDS AND DERIVATIVES OF DIBENCILAMINE. | |
| UY28243A1 (en) | QUINOLINE AND QUNOXALINE COMPOUNDS | |
| SV2003000886A (en) | PPAR AGONISTS REF. PC11023AADO / BB | |
| UY28097A1 (en) | PPAR ACTIVATORS | |
| CR9012A (en) | 4-AMINO-SUBSTITUTED-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINE COMPOUNDS | |
| PA8539101A1 (en) | PPAR COMPOUNDS | |
| UY29124A1 (en) | QUINOLINE COMPOUNDS | |
| ECSP088729A (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| BRPI0607839A2 (en) | substituted 1,1,1-trifluoro-3 - [(benzyl) - (pyrimidin-2-yl) amino] propan-2-ol compounds | |
| DOP2005000179A (en) | QUINOLINE COMPOUND | |
| DOP2002000327A (en) | PPAR AGONISTS | |
| CU20080164A7 (en) | DIBENCILAMINE COMPOUNDS AND DERIVATIVES | |
| UY27168A1 (en) | PPAR AGONISTS | |
| ECSP088730A (en) | DIBENCILAMINE DERIVATIVES AS CETP INHIBITORS | |
| DOP2005000238A (en) | COMPOUNDS AND DERIVATIVES OF DIBENCIL AMINA | |
| UY27158A1 (en) | PPAR COMPOUNDS | |
| DOP2004000863A (en) | QUINOLINE AND QUINOXALINE COMPOUNDS | |
| DOP2002000331A (en) | PPAR COMPOUND | |
| DOP2003000762A (en) | PPAR ACTIVATORS | |
| UY29123A1 (en) | 4-AMINO-SUBSTITUTED-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINE COMPOUNDS | |
| SV2006002314A (en) | COMPOUNDS AND DERIVATIVES OF DIBENCIL AMINA REF. NO. PC32592A | |
| DOP2005000182A (en) | 4-AMINO-SUBSTITUTED-2-SUBSTITUTED-1,2,3-TETRAHYDROQUINOLINE COMPOUNDS | |
| PA8589501A1 (en) | PPAR ACTIVATORS | |
| ECSP993135A (en) | 1,2,3,4- TETRAHIDROQUINOLINAS -2-SUBSTITUTED 4- AMINO SUBSTITUTED |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20160530 |